Skip to content
Markets News
Stocks1 min read

McKesson Slides as Investors Look Ahead to November Earnings

Makkler Newsroom
September 30, 2026

The shares underperformed the S&P 500 in the latest session, while analysts’ consensus calls for higher earnings and revenue in the upcoming report.

McKesson closed at $853.81, down 1.27% in the latest trading session. The decline was steeper than the S&P 500’s 0.25% loss. The Dow fell 0.86%, while the Nasdaq gained 0.24%.

The shares had lost 4.63% over the past month, compared with a 1.01% decline in the Medical sector and a 0.42% drop in the S&P 500, according to the article.

McKesson is scheduled to report earnings on November 4. Zacks consensus estimates call for earnings of $10.72 per share and revenue of $110.14 billion for the quarter. Those figures would represent year-over-year increases of 8.72% and 6.78%, respectively.

For the full year, Zacks estimates earnings of $44.64 per share and revenue of $429.09 billion. The projections represent gains of 14.14% and 6.36% from the prior year, respectively.

The Zacks consensus estimate for earnings per share edged 0.02% lower over the past month. The publisher also reported that McKesson’s forward price-to-earnings ratio was 19.37, compared with 17.02 for its industry.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.